Burns Matteson Capital Management »

Takeda Pharmaceutical shares owned by Burns Matteson Capital Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Burns Matteson Capital Management from 13F filings

Historical chart of Burns Matteson Capital Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Burns Matteson Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Burns Matteson Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $424k 27k 16.03

More positions owned by Burns Matteson Capital Management

Corning Stock (GLW)
Invesco S&p 500 Quality Etf Etf (SPHQ)
State Street Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Ishares 5-10 Year Investment Grade Corporate Bond Etf Etf (IGIB)
Pacer Us Cash Cows 100 Etf Etf (COWZ)
Ishares Russell Top 200 Growth Etf Etf (IWY)
Wisdomtree Dynamic International Equity Fund Etf (DDWM)
Ishares Currency Hedged Msci Eafe Etf Etf (HEFA)
Schwab Us Dividend Equity Etf Etf (SCHD)
Invesco S&p Midcap Quality Etf Etf (XMHQ)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Spdr Gold Shares Etf (GLD)
Wisdomtree Us Quality Dividend Growth Fund Etf (DGRW)
Ishares Russell Mid-cap Growth Etf Etf (IWP)
Omega Healthcare Invs Reit (OHI)

View all positions for Burns Matteson Capital Management

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
FMR
Morgan Stanley
Adage Capital Partners GP
Goldman Sachs Group
Brandes Investment Partners
BlackRock
Arrowstreet Capital, Limited Partnership
Renaissance Technologies
UBS Group
D. E. Shaw & Co
Van Eck Associates Corp.
Citadel Advisors
First Trust Advisors
Northern Trust

View all funds holding Takeda Pharmaceutical